评估风险分层模型相互作用的框架:卵巢癌的例子
Minh Tung Phung1, Alice W Lee2, Karen McLean3
1Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Journal of the National Cancer Institute
|July 12, 2023
概括
准确的卵巢癌风险模型需要评估风险因素之间的相互作用. 更年期状态显著改变了诸如子宫内膜异位症和家族病史等因素对疾病风险的影响.
科学领域:
- 生殖流行病学 生殖流行病学
- 癌症基因组学 癌症基因组学
- 生物统计学 生物统计学
背景情况:
- 当前的癌症风险分层模型往往忽视了风险和保护因素之间的相互作用.
- 开发更精确的模型需要全面了解暴露如何影响疾病易感性.
研究的目的:
- 引入和应用一个新的4个标准框架来评估卵巢癌风险因素之间的相互作用.
- 通过结合相互作用分析,提高卵巢癌风险预测模型的准确性.
主要方法:
- 利用了来自卵巢癌协会联盟的9项病例控制研究的数据.
- 进行了对15个风险/保护因素 (14个非遗传,1个多遗传得分) 和更年期状态之间的相互作用的全面分析.
- 评估了已识别的风险和保护因素之间的双对相互作用.
主要成果:
- 确定更年期状态显著改变了几个因素 (子宫内膜异位症,家族病史,母乳养,使用荷尔蒙避孕药) 与卵巢癌风险之间的关联.
- 证明了在风险预测中考虑乘法相互作用的重要性.
结论:
- 开发的四个标准框架为评估癌症研究中的暴露相互作用提供了一个强大的方法.
- 纳入更年期状态特定的相互作用分析对于完善卵巢癌风险分层模型至关重要.
相关概念视频
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Comparing the Survival Analysis of Two or More Groups
226
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
226
Relative Risk
225
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
225
Odds Ratio
173
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
173
Strategies for Assessing and Addressing Confounding
121
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
121


